Literature DB >> 7866217

Clinical pharmacology and therapeutics.

A Breckenridge1.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7866217      PMCID: PMC2548766          DOI: 10.1136/bmj.310.6976.377

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris.

Authors:  J McMurray; A Rankin
Journal:  BMJ       Date:  1994-11-19

2.  Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum.

Authors:  K Shibuki; D Okada
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

3.  Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.

Authors:  D A Cooper; J M Gatell; S Kroon; N Clumeck; J Millard; F D Goebel; J N Bruun; G Stingl; R L Melville; J González-Lahoz
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

4.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

5.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

Review 6.  L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial.

Authors:  W J Burke; W H Roccaforte; S P Wengel; B L Bayer; A E Ranno; N K Willcockson
Journal:  J Am Geriatr Soc       Date:  1993-11       Impact factor: 5.562

7.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

Authors:  F Cambien; O Poirier; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; J M Bard; L Bara; S Ricard
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

8.  Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients.

Authors:  B L Laube; A Georgopoulos; G K Adams
Journal:  JAMA       Date:  1993-04-28       Impact factor: 56.272

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

Authors:  K Swedberg; P Held; J Kjekshus; K Rasmussen; L Rydén; H Wedel
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

View more
  1 in total

1.  The bridging function of clinical pharmacology.

Authors:  Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-09       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.